Tamoxifen liposomal
Alternative Names: Liposomal tamoxifenLatest Information Update: 17 Dec 2021
At a glance
- Originator Max-Delbruck Centre for Molecular Medicine
- Class Antineoplastics; Chemopreventatives; Dimethylamines; Infertility therapies; Phenyl ethers; Small molecules; Stilbenes
- Mechanism of Action Estrogen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer
Most Recent Events
- 19 Aug 2019 BTG has been acquired by Boston Scientific Corporation
- 08 Aug 2006 No development reported - Preclinical for Breast cancer in Europe (PO)
- 12 Nov 2001 Preclinical development for Breast cancer in Europe (PO)